Vimarsana
Biggest News Aggregation in the World

Dave Marver News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dave Marver. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dave Marver Today - Breaking & Trending Today

ONWARD Medical NV: ONWARD® Medical Reports Q1 2024 Update and Year-to-Date Highlights - Vimarsana News

ONWARD Medical NV: ONWARD® Medical Reports Q1 2024 Update and Year-to-Date Highlights

Nature Medicine published Up-LIFT pivotal trial results Submitted FDA De Novo application for ARC-EX® System Successfully raised EUR 20M in equity capital EINDHOVEN, the Netherlands, May 23

Onward ARC-EX nerve stim hits pivotal trial endpoints - Vimarsana News

Onward ARC-EX nerve stim hits pivotal trial endpoints

Onward Medical announced positive data supporting the use of its ARC-EX nerve stimulation therapy for restoring upper limb movement.

Related Topics:
Dave MarverNature Medicine
ONWARD® Medical Reports Full Year 2023 Financial and Operating Results and Shares 2024 Highlights Year-to-Date - Vimarsana News

ONWARD® Medical Reports Full Year 2023 Financial and Operating Results and Shares 2024 Highlights Year-to-Date

Submitted FDA De Novo application for ARC-EX® System Successfully raised EUR 20M in equity capital Announced positive top-line results from Up-LIFT pivotal study Forged partnership to provide...

Stifel Initiates Research Coverage of ONWARD® Medical with a Buy Rating and Target Price of EUR 12.00 - Vimarsana News

Stifel Initiates Research Coverage of ONWARD® Medical with a Buy Rating and Target Price of EUR 12.00

EINDHOVEN, the Netherlands, April 09, 2024 -- ONWARD Medical N.V. , the medical technology company creating innovative therapies to restore movement, function, and independence in people with...

KBC Securities Initiates Research Coverage of ONWARD® Medical with a Buy Rating and Target Price of EUR 10.00 Per Share - Vimarsana News

KBC Securities Initiates Research Coverage of ONWARD® Medical with a Buy Rating and Target Price of EUR 10.00 Per Share

EINDHOVEN, the Netherlands, Feb. 09, 2024 -- ONWARD Medical N.V. , the medical technology company creating innovative therapies to restore movement, function, and independence in people with spinal...